Author Information
Frederic C. H. Amant is affiliated with several prestigious institutions, including the Departments of Oncology, Gynecology, and Obstetrics at University Hospitals Leuven in Leuven. Additionally, he is associated with the Center for Gynecological Oncology Amsterdam, the Academic Medical Centre Amsterdam-University of Amsterdam, and The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital in Amsterdam, The Netherlands. His extensive affiliations highlight his prominent role in the field of gynecological oncology.
Research Contributions
Frederic C. H. Amant has made significant contributions to the field of gynecology, particularly in the areas of uterine and endometrial cancer, chemotherapy during pregnancy, and the molecular profiling of cancers. His research includes the differentiation of uterine leiomyomas and leiomyosarcomas, risk stratification of endometrial cancer patients, and the association of chemotherapy timing in pregnancy with congenital malformations. Additionally, his work on the expression of TRP channels in high-risk endometrial carcinoma and comprehensive genome-wide analysis for cancer prediction showcases his diverse research interests and impact on gynecological oncology.
Aliases
The author is known by various aliases, including F. Amant, F Amant, F. C. H. Amant, Frédéric C Amant, Frédéric Amant, F C H Amant, F. C. Amant, F C Amant, Frederic Amant, Fréderic Amant, and Frederic C. H. Amant. Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
27,536 |
| h-index |
80 |
| Paper Count |
862 |
